|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
de Martel C, Ferlay J, Franceschi S, et
al: Global burden of cancers attributable to infections in 2008: a
review and synthetic analysis. Lancet Oncol. 13:607–615.
2012.PubMed/NCBI
|
|
3
|
Benamrouz S, Conseil V, Creusy C, Calderon
E, Dei-Cas E and Certad G: Parasites and malignancies, a review,
with emphasis on digestive cancer induced by Cryptosporidium parvum
(Alveolata: Apicomplexa). Parasite. 19:101–115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Oliveira EC, Leite MS, Miranda JA, et al:
Chronic Trypanosoma cruzi infection associated with low
incidence of 1,2-dimethylhydrazine-induced colon cancer in rats.
Carcinogenesis. 22:737–740. 2001.
|
|
5
|
Chen L, He Z, Qin L, et al: Antitumor
effect of malaria parasite infection in a murine Lewis lung cancer
model through induction of innate and adaptive immunity. PLoS One.
6:e244072011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang XL, Fu BQ, Yang SJ, et al:
Trichinella spiralis - a potential antitumor agent. Vet
Parasitol. 159:249–252. 2009. View Article : Google Scholar
|
|
7
|
Akgül H, Tez M, Unal AE, Keşkek M, Sayek I
and Ozçelik T: Echinococcus against cancer: why not? Cancer Immunol
Immunother. 98:1999–2000. 2003.
|
|
8
|
Darani HY and Yousefi M: Parasites and
cancers: parasite antigens as possible targets for cancer
immunotherapy. Future Oncol. 8:1529–1235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yousofi Darani H, Soozangar N, Khorami S,
Taji F, Yousofi M and Shirzad H: Hydatid cyst protoscolices induce
cell death in WEHI-164 fibrosarcoma cells and inhibit the
proliferation of baby hamster kidney fibroblasts in vitro. J
Parasitol Res. 304183:January 31–2012. View Article : Google Scholar
|
|
10
|
Medzhitov R: Recognition of microorganisms
and activation of the immune response. Nature. 449:819–826. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Palucka AK, Ueno H, Fay JW and Banchereau
J: Taming cancer by inducing immunity via dendritic cells. Immunol
Rev. 220:129–150. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Correale J and Farez M: Helminth antigens
modulate immune responses in cells from multiple sclerosis patients
through TLR2-dependent mechanisms. J Immunol. 183:5999–6012. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Elliott DE and Weinstock JV: Helminth-host
immunological interactions: prevention and control of
immune-mediated diseases. Ann NY Acad Sci. 1247:83–96. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
van Vliet SJ, van Liempt E, Saeland E, et
al: Carbohydrate profiling reveals a distinctive role for the
C-type lectin MGL in the recognition of helminth parasites and
tumor antigens by dendritic cells. Int Immunol. 17:661–669.
2005.PubMed/NCBI
|
|
15
|
Vanhoutte F, Breuilh L, Fontaine J, et al:
Toll-like receptor (TLR)2 and TLR3 sensing is required for
dendritic cell activation, but dispensable to control
Schistosoma mansoni infection and pathology. Microbes
Infect. 9:1606–1613. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cummings RD and Nyame AK: Schistosome
glysoconjugates. Biochim Biophys Acta. 1455:363–374. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Doedens A, Loukas A and Maizels RM: A cDNA
encoding Tc-MUC-5, a mucin from Toxocara canis larvae identified by
expression screening. Acta Trop. 79:211–217. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Theodoropoulos G, Hicks SJ, Corfield AP,
Miller BG and Carrington SD: The role of mucins in host-parasite
interactions: Part II - helminth parasites. Trends Parasitol.
17:130–135. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Thomas PG and Harn DAJ: Immune biasing by
helminth glycans. Cell Microbiol. 6:13–22. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alvarez Errico D, Medeiros A, Míguez M, et
al: O-glycosylation in Echinococcus granulosus:
identification and characterization of the carcinoma-associated Tn
antigen. Exp Parasitol. 98:100–109. 2001.
|
|
21
|
Brockhausen I: Mucin-type O-glycans
in human colon and breast cancer: glycodynamics and functions. EMBO
Rep. 7:599–604. 2006.
|
|
22
|
Schietinger A, Philip M, Yoshida BA, Azadi
P, Liu H, Meredith SC and Schreiber H: A mutant chaperone converts
a wild-type protein into a tumor-specific antigen. Science.
314:304–308. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Baldus SE, Engelmann K and Hanisch FG:
MUC1 and the MUCs: a family of human mucins with impact in cancer
biology. Crit Rev Clin Lab Sci. 41:189–231. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carraway KL III, Funes M, Workman HC and
Sweeney C: Contribution of membrane mucins to tumor progression
through modulation of cellular growth signaling pathways. Curr Top
Dev Biol. 78:1–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Freire T and Osinaga E: The sweet side of
tumor immunotherapy. Immunotherapy. 4:719–734. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kufe DW: Mucins in cancer: function,
prognosis and therapy. Nat Rev Cancer. 9:874–885. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Beatson RE, Taylor-Papadimitriou J and
Burchell JM: MUC1 immunotherapy. Immunotherapy. 2:305–327. 2010.
View Article : Google Scholar
|
|
28
|
Quoix E, Ramlau R, Westeel V, et al:
Therapeutic vaccination with TG4010 and first-line chemotherapy in
advanced non-small-cell lung cancer: a controlled phase 2B trial.
Lancet Oncol. 12:1125–1133. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Slovin SF, Ragupathi G, Musselli C, et al:
Fully synthetic carbohydrate-based vaccines in biochemically
relapsed prostate cancer: clinical trial results with
alpha-N-acetylgalactosamine-O-serine/threonine conjugate vaccine. J
Clin Oncol. 21:4292–4298. 2003. View Article : Google Scholar
|
|
30
|
Fernandez C, Gregory WF, Loke P and
Maizels RM: Full-length-enriched cDNA libraries from
Echinococcus granulosus contain separate populations of
oligo-capped and trans-spliced transcripts and a high level of
predicted signal peptide sequences. Mol Biochem Parasitol.
122:171–180. 2002.PubMed/NCBI
|
|
31
|
Coïc YM, Lan CL, Neumann JM, Jamin N and
Baleux F: Slightly modifying pseudoproline dipeptides incorporation
strategy enables solid phase synthesis of a 54 AA fragment of
caveolin-1 encompassing the intramembrane domain. J Pept Sci.
16:98–104. 2010.
|
|
32
|
Lo-Man R, Vichier-Guerre S, Perraut R, et
al: A fully synthetic therapeutic vaccine candidate targeting
carcinoma-associated Tn carbohydrate antigen induces tumor-specific
antibodies in nonhuman primates. Cancer Res. 64:4987–4994. 2004.
View Article : Google Scholar
|
|
33
|
Rosa DS, Ribeiro SP and Cunha-Neto E:
CD4+ T cell epitope discovery and rational vaccine
design. Arch Immunol Ther Exp. 58:121–130. 2010.
|
|
34
|
Lo-Man R, Vichier-Guerre S, Bay S, Deriaud
E, Cantacuzene D and Leclerc C: Antitumor immunity provided by a
synthetic multiple antigenic glycopeptide displaying a tri-Tn
glycotope. J Immunol. 166:2849–2854. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Singhal AK: Histo-blood group antigens in
cancer. Semin Cancer Biol. 2:379–388. 1991.PubMed/NCBI
|
|
36
|
Singh SK, Streng-Ouwehand I, Litjens M, et
al: Characterization of murine MGL1 and MGL2 C-type lectins:
distinct glycan specificities and tumor binding properties. Mol
Immunol. 46:1240–1249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hubert P, Heitzmann A, Viel S, et al:
Antibody-dependent cell cytotoxicity synapses form in mice during
tumor-specific antibody immunotherapy. Cancer Res. 71:5134–5143.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Quezada SA, Simpson TR, Peggs KS, et al:
Tumor-reactive CD4(+) T cells develop cytotoxic activity and
eradicate large established melanoma after transfer into
lymphopenic hosts. J Exp Med. 207:637–650. 2010.
|
|
39
|
Baird JR, Byrne KT, Lizotte PH, et al:
Immune-mediated regression of established B16F10 melanoma by
intratumoral injection of attenuated Toxoplasma gondii protects
against rechallenge. J Immunol. 190:469–478. 2013. View Article : Google Scholar
|
|
40
|
Villegas FR, Coca S, Villarrubia VG, et
al: Prognostic significance of tumor infiltrating natural killer
cells subset CD57 in patients with squamous cell lung cancer. Lung
Cancer. 35:23–28. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Malhotra A and Shanker A: NK cells: immune
cross-talk and therapeutic implications. Immunotherapy.
3:1143–1166. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Walzer T, Dalod M, Robbins SH, Zitvogel L
and Vivier E: Natural-killer cells and dendritic cells: ‘l'union
fait la force’. Blood. 106:2252–2258. 2005.
|
|
43
|
Prestwich RJ, Errington F, Steele LP, et
al: Reciprocal human dendritic cell-natural killer cell
interactions induce antitumor activity following tumor cell
infection by oncolytic reovirus. J Immunol. 183:4312–4321. 2009.
View Article : Google Scholar
|
|
44
|
Gerosa F, Gobbi A, Zorzi P, et al: The
reciprocal interaction of NK cells with plasmacytoid or myeloid
dendritic cells profoundly affects innate resistance functions. J
Immunol. 174:727–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Blalock LT, Landsberg J, Messmer M, et al:
Human dendritic cells adenovirally-engineered to express three
defined tumor antigens promote broad adaptive and innate immunity.
Oncoimmunology. 1:287–357. 2012. View Article : Google Scholar
|
|
46
|
van Die I, van Stijn CM, Geyer H and Geyer
R: Structural and functional analysis of glycosphingolipids of
Schistosoma mansoni. Methods Enzymol. 480:117–140.
2010.PubMed/NCBI
|
|
47
|
Truchetet ME, Beven L, Renaudin H, et al:
Potential role of Mycoplasma hominis in interleukin
(IL)-17-producing CD4+ T-cell generation via induction
of IL-23 secretion by human dendritic cells. J Infect Dis.
204:1796–1805. 2011.PubMed/NCBI
|
|
48
|
Gowda DC: TLR-mediated cell signaling by
malaria GPIs. Trends Parasitol. 23:596–604. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Campos MA, Almeida IC, Takeuchi O, et al:
Activation of Toll-like receptor-2 by glycosylphosphatidylinositol
anchors from a protozoan parasite. J Immunol. 167:416–423. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Junqueira C, Guerrero AT, Galvão-Filho B,
et al: Trypanosoma cruzi adjuvants potentiate T
cell-mediated immunity induced by a NY-ESO-1 based antitumor
vaccine. PLoS One. 7:e362452012. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tarang S, Kumar S and Batra SK: Mucins and
toll-like receptors: kith and kin in infection and cancer. Cancer
Lett. 321:110–119. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Freire T, Lo-Man R, Bay S and Leclerc C:
Tn glycosylation of the MUC6 protein modulates its immunogenicity
and promotes the induction of Th17-biased T cell responses. J Biol
Chem. 286:7797–7811. 2011. View Article : Google Scholar : PubMed/NCBI
|
